1
|
New perspectives in cell adhesion: RGD and integrins.
|
Science
|
1987
|
18.41
|
2
|
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.
|
Nature
|
1984
|
14.25
|
3
|
Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.
|
Cell
|
1985
|
8.55
|
4
|
Arg-Gly-Asp: a versatile cell recognition signal.
|
Cell
|
1986
|
7.89
|
5
|
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.
|
Science
|
1986
|
5.58
|
6
|
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
|
Proc Natl Acad Sci U S A
|
1984
|
5.13
|
7
|
A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin.
|
Proc Natl Acad Sci U S A
|
1985
|
4.44
|
8
|
Amino acid sequence of the human fibronectin receptor.
|
J Cell Biol
|
1987
|
4.08
|
9
|
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
|
Nature
|
1992
|
3.96
|
10
|
Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule.
|
Cell
|
1981
|
3.64
|
11
|
Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
|
Proc Natl Acad Sci U S A
|
1983
|
3.23
|
12
|
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin.
|
EMBO J
|
1985
|
2.69
|
13
|
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
|
Proc Natl Acad Sci U S A
|
1985
|
2.64
|
14
|
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors.
|
Proc Natl Acad Sci U S A
|
1986
|
2.58
|
15
|
Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs.
|
J Biol Chem
|
1987
|
2.29
|
16
|
Detachment of cells from culture substrate by soluble fibronectin peptides.
|
J Cell Biol
|
1985
|
2.26
|
17
|
Arginine-glycine-aspartic acid adhesion receptors.
|
Methods Enzymol
|
1987
|
2.25
|
18
|
A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence.
|
J Cell Biol
|
1987
|
2.04
|
19
|
The cell attachment domain of fibronectin. Determination of the primary structure.
|
J Biol Chem
|
1982
|
2.03
|
20
|
Alpha 2 beta 1 integrins from different cell types show different binding specificities.
|
J Biol Chem
|
1990
|
1.92
|
21
|
Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release.
|
Biochem J
|
1997
|
1.85
|
22
|
Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion.
|
J Biol Chem
|
1985
|
1.81
|
23
|
Vitronectin--a major cell attachment-promoting protein in fetal bovine serum.
|
Exp Cell Res
|
1985
|
1.81
|
24
|
A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.
|
J Cell Biol
|
1993
|
1.74
|
25
|
Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
|
J Cell Biol
|
1988
|
1.65
|
26
|
cDNA sequences from the alpha subunit of the fibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide.
|
J Biol Chem
|
1986
|
1.51
|
27
|
An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.
|
J Cell Biol
|
1987
|
1.44
|
28
|
Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
|
J Cell Biol
|
1986
|
1.42
|
29
|
Domain structure of vitronectin. Alignment of active sites.
|
J Biol Chem
|
1984
|
1.38
|
30
|
Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts.
|
J Biol Chem
|
1984
|
1.38
|
31
|
Calcium as a potential physiological regulator of integrin-mediated cell adhesion.
|
J Biol Chem
|
1991
|
1.26
|
32
|
Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
|
Biochem Pharmacol
|
1997
|
1.21
|
33
|
Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa.
|
J Biol Chem
|
1990
|
1.20
|
34
|
Extracellular matrices and cell adhesion.
|
Arteriosclerosis
|
1985
|
1.20
|
35
|
Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets.
|
Blood
|
1987
|
1.20
|
36
|
Regulation of alpha 2 beta 1-mediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+.
|
J Cell Biol
|
1992
|
1.15
|
37
|
T-lymphocyte differentiation and the extracellular matrix: identification of a thymocyte subset that attaches specifically to fibronectin.
|
Proc Natl Acad Sci U S A
|
1986
|
1.11
|
38
|
Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.
|
Stroke
|
2000
|
1.10
|
39
|
Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor.
|
J Cell Biol
|
1987
|
1.10
|
40
|
Preferential expression of fibronectin receptors on immature thymocytes.
|
J Cell Biol
|
1988
|
1.07
|
41
|
The cell attachment determinant in fibronectin.
|
J Cell Biochem
|
1985
|
1.04
|
42
|
Purification and characterization of vitronectin.
|
Methods Enzymol
|
1987
|
0.99
|
43
|
Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response.
|
J Clin Invest
|
1995
|
0.98
|
44
|
Identification of fibronectin receptors on T lymphocytes.
|
J Cell Biol
|
1987
|
0.94
|
45
|
Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
|
J Med Chem
|
1994
|
0.91
|
46
|
Concept and progress in the development of RGD-containing peptide pharmaceuticals.
|
Biopolymers
|
1995
|
0.90
|
47
|
Changes in the concentrations of extracellular Mg++ and Ca++ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin function, activating keratinocyte migration on type I collagen.
|
J Invest Dermatol
|
1995
|
0.90
|
48
|
Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization.
|
Biomaterials
|
1997
|
0.88
|
49
|
The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties.
|
Connect Tissue Res
|
1989
|
0.82
|
50
|
A 30 kD sulfated extracellular matrix protein immunologically crossreactive with vitronectin.
|
Matrix
|
1993
|
0.80
|
51
|
Effects of an arginine-glycine-aspartic acid peptide-containing artificial matrix on epithelial migration in vitro and experimental second-degree burn wound healing in vivo.
|
J Burn Care Rehabil
|
1997
|
0.79
|
52
|
Role of transforming growth factor beta and decorin in controlling fibrosis.
|
Methods Enzymol
|
1994
|
0.78
|
53
|
Inhibition of thrombosis by a selective fibrinogen receptor antagonist without effect on bleeding time.
|
Thromb Haemost
|
1994
|
0.78
|
54
|
Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding time.
|
Coron Artery Dis
|
1993
|
0.78
|
55
|
Comparison of two phosphoproteins in chicken bone and their similarities to the mammalian bone proteins, osteopontin and bone sialoprotein II.
|
Biochem Biophys Res Commun
|
1990
|
0.78
|
56
|
In vitro induction of E-rosette formation in human bone marrow cells by the thymic proteins LSHr and LSHh.
|
Immunopharmacology
|
1979
|
0.75
|
57
|
Biological activity of the pure thymus protein, LSHr.
|
Ann N Y Acad Sci
|
1979
|
0.75
|
58
|
Therapeutic application of matrix biology.
|
Methods Enzymol
|
1994
|
0.75
|
59
|
Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time.
|
J Lab Clin Med
|
1994
|
0.75
|